A carregar...
SMYD2 promotes cervical cancer growth by stimulating cell proliferation
BACKGROUND: Cervical cancer is the most common gynecological malignancy with low terminal cure rate, and therefore new therapeutic targets are urgently needed to combat this disease. SMYD2, as an oncogene, is abnormal highly expressed in multiple types of tumors and further affects the occurrence an...
Na minha lista:
| Publicado no: | Cell Biosci |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6749660/ https://ncbi.nlm.nih.gov/pubmed/31548876 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13578-019-0340-9 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|